Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 913 of 1,261
  1. US 8232406

    c-MET protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted
  2. US 8232408

    Crystalline 1-(3-fluorophenyl)-5-methyl-2-(1H)pyridone, the preparation methods, compositions and applications thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted
  3. US 8232448

    Transgenic mouse with a homozygous mutation in the CMAH gene

    The Regents of the University of California · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted
  4. US 8232379

    Nucleic acids encoding chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted
  5. US 8232294

    Amino ester derivatives, sailts thereof and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted
  6. US 8232320

    Antimicrobial nanoemulsion compositions and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted
  7. US 8232373

    Immunogenic peptide composition for the prevention and treatment of alzheimer's disease

    United Biomedical, Inc. · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted
  8. US 8232302

    Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted
  9. US 8232316

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted
  10. US 8232259

    Multiple CpG oligodeoxynucleotide and their use to induce an immune response

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted
  11. US 8227497

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  12. US 8227555

    Hydrolytically stable maleimide-terminated polymers

    Nektar Therapeutics · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  13. US 8227487

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  14. US 8227615

    Pyridyl derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  15. US 8227583

    Vaccines containing canine parvovirus genetic variants

    The Board of Regents for Oklahoma State University · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  16. US 8227516

    Compounds as histone deacetylase inhibitors

    4SC DISCOVERY GMBH · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  17. US 8227558

    Method for preparing polymer maleimides

    Nektar Therapeutics · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  18. US 8227661

    Methods of identifying agents that ameliorate or modulate effects of PRO1328 gene disruptions

    Lexicon Genetics, Inc. · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  19. US 8227230

    Human lysosomal proteins from plant cell culture

    Protalix Ltd. · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  20. US 8226980

    Orally disintegrating solid dosage forms comprising progestin and methods of making and using thereof

    TEVA WOMEN'S HEALTH, INC. · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  21. US 8227432

    Transposon system and methods of use

    Regents of the University of Minnesota · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  22. US 8227443

    Silencing of CSN5 gene expression using interfering RNA

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  23. US 8227455

    Methods of treating cell proliferative disorders

    Rigel Pharmaceuticals, Inc. · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  24. US 8227473

    Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

    Lixte Biotechnology, Inc. · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.